Health data cooperatives - Citizen empowerment

Ernst Hafen, D. Kossmann, A. Brand

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Introduction: This article is part of a Focus Theme of Methods of Information in Medicine on Health Record Banking. Background: Healthcare is often ineffective and costs are steadily rising. This is in a large part due to the inaccessibility of medical and health data stored in multiple silos. Further - more, in most cases molecular differences between individuals that result in different susceptibilities to drugs and diseases as well as targeted interventions cannot be taken into account. Technological advances in genome sequencing and the interaction of'omics' data with environmental data on one hand and mobile health on the other, promise to generate the longitudinal health data that will form the basis for a more personalized, precision medicine. Objectives: For this new medicine to become a reality, however, millions of personal health data sets have to be aggregated. The value of such aggregated personal data has been recognized as a new asset class and many commercial entities are competing for this new asset (e.g. Google, Facebook, 23andMe, PatientsLikeMe). The primary source and beneficiary of personal health data is the individual. As a collective, society should be the beneficiary of both the economic and health value of these aggregated data and (health) information. Methods: We posit that empowering citizens by providing them with a platform to safely store, manage and share their healthrelated data will be a necessary element in the transformation towards a more effective and efficient precision medicine. Such health data platforms should be organized as cooperatives that are solely owned and controlled by their members and not by shareholders. Members determine which data they want to share for example with doctors or to contribute to research for the benefit of their health and that of society. Members will also decide how the revenues generated by granting third parties access to the anonymized data that they agreed to share, should be invested in research, information or education. Results: Currently no functional Health Data Cooperatives exist yet. The relative success of health data repositories such as 23andme and PatientsLikeMe indicates that citizens are willing to participate in research even if - and in contrast to the cooperative model - the commercial value of these data does not go back to the collective of users. Conclusions: In the Health Data Cooperative model, the citizens with their data would take the center stage in the healthcare system and society would benefit from the health-related and financial benefits that aggregation of these data brings.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalMethods of Information in Medicine
Volume53
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Health
Precision Medicine
Insurance Benefits
Power (Psychology)
Research
Medicine
Delivery of Health Care
Telemedicine
Individuality
Economics
Genome
Education
Costs and Cost Analysis
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Health Informatics
  • Health Information Management
  • Advanced and Specialised Nursing
  • Medicine(all)

Cite this

Hafen, Ernst ; Kossmann, D. ; Brand, A. / Health data cooperatives - Citizen empowerment. In: Methods of Information in Medicine. 2014 ; Vol. 53, No. 2. pp. 82-86.
@article{e3e998b429644902ad3314589477f67c,
title = "Health data cooperatives - Citizen empowerment",
abstract = "Introduction: This article is part of a Focus Theme of Methods of Information in Medicine on Health Record Banking. Background: Healthcare is often ineffective and costs are steadily rising. This is in a large part due to the inaccessibility of medical and health data stored in multiple silos. Further - more, in most cases molecular differences between individuals that result in different susceptibilities to drugs and diseases as well as targeted interventions cannot be taken into account. Technological advances in genome sequencing and the interaction of'omics' data with environmental data on one hand and mobile health on the other, promise to generate the longitudinal health data that will form the basis for a more personalized, precision medicine. Objectives: For this new medicine to become a reality, however, millions of personal health data sets have to be aggregated. The value of such aggregated personal data has been recognized as a new asset class and many commercial entities are competing for this new asset (e.g. Google, Facebook, 23andMe, PatientsLikeMe). The primary source and beneficiary of personal health data is the individual. As a collective, society should be the beneficiary of both the economic and health value of these aggregated data and (health) information. Methods: We posit that empowering citizens by providing them with a platform to safely store, manage and share their healthrelated data will be a necessary element in the transformation towards a more effective and efficient precision medicine. Such health data platforms should be organized as cooperatives that are solely owned and controlled by their members and not by shareholders. Members determine which data they want to share for example with doctors or to contribute to research for the benefit of their health and that of society. Members will also decide how the revenues generated by granting third parties access to the anonymized data that they agreed to share, should be invested in research, information or education. Results: Currently no functional Health Data Cooperatives exist yet. The relative success of health data repositories such as 23andme and PatientsLikeMe indicates that citizens are willing to participate in research even if - and in contrast to the cooperative model - the commercial value of these data does not go back to the collective of users. Conclusions: In the Health Data Cooperative model, the citizens with their data would take the center stage in the healthcare system and society would benefit from the health-related and financial benefits that aggregation of these data brings.",
author = "Ernst Hafen and D. Kossmann and A. Brand",
year = "2014",
doi = "10.3414/ME13-02-0051",
language = "English",
volume = "53",
pages = "82--86",
journal = "Methods of Information in Medicine",
issn = "0026-1270",
publisher = "Schattauer GmbH",
number = "2",

}

Health data cooperatives - Citizen empowerment. / Hafen, Ernst; Kossmann, D.; Brand, A.

In: Methods of Information in Medicine, Vol. 53, No. 2, 2014, p. 82-86.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Health data cooperatives - Citizen empowerment

AU - Hafen, Ernst

AU - Kossmann, D.

AU - Brand, A.

PY - 2014

Y1 - 2014

N2 - Introduction: This article is part of a Focus Theme of Methods of Information in Medicine on Health Record Banking. Background: Healthcare is often ineffective and costs are steadily rising. This is in a large part due to the inaccessibility of medical and health data stored in multiple silos. Further - more, in most cases molecular differences between individuals that result in different susceptibilities to drugs and diseases as well as targeted interventions cannot be taken into account. Technological advances in genome sequencing and the interaction of'omics' data with environmental data on one hand and mobile health on the other, promise to generate the longitudinal health data that will form the basis for a more personalized, precision medicine. Objectives: For this new medicine to become a reality, however, millions of personal health data sets have to be aggregated. The value of such aggregated personal data has been recognized as a new asset class and many commercial entities are competing for this new asset (e.g. Google, Facebook, 23andMe, PatientsLikeMe). The primary source and beneficiary of personal health data is the individual. As a collective, society should be the beneficiary of both the economic and health value of these aggregated data and (health) information. Methods: We posit that empowering citizens by providing them with a platform to safely store, manage and share their healthrelated data will be a necessary element in the transformation towards a more effective and efficient precision medicine. Such health data platforms should be organized as cooperatives that are solely owned and controlled by their members and not by shareholders. Members determine which data they want to share for example with doctors or to contribute to research for the benefit of their health and that of society. Members will also decide how the revenues generated by granting third parties access to the anonymized data that they agreed to share, should be invested in research, information or education. Results: Currently no functional Health Data Cooperatives exist yet. The relative success of health data repositories such as 23andme and PatientsLikeMe indicates that citizens are willing to participate in research even if - and in contrast to the cooperative model - the commercial value of these data does not go back to the collective of users. Conclusions: In the Health Data Cooperative model, the citizens with their data would take the center stage in the healthcare system and society would benefit from the health-related and financial benefits that aggregation of these data brings.

AB - Introduction: This article is part of a Focus Theme of Methods of Information in Medicine on Health Record Banking. Background: Healthcare is often ineffective and costs are steadily rising. This is in a large part due to the inaccessibility of medical and health data stored in multiple silos. Further - more, in most cases molecular differences between individuals that result in different susceptibilities to drugs and diseases as well as targeted interventions cannot be taken into account. Technological advances in genome sequencing and the interaction of'omics' data with environmental data on one hand and mobile health on the other, promise to generate the longitudinal health data that will form the basis for a more personalized, precision medicine. Objectives: For this new medicine to become a reality, however, millions of personal health data sets have to be aggregated. The value of such aggregated personal data has been recognized as a new asset class and many commercial entities are competing for this new asset (e.g. Google, Facebook, 23andMe, PatientsLikeMe). The primary source and beneficiary of personal health data is the individual. As a collective, society should be the beneficiary of both the economic and health value of these aggregated data and (health) information. Methods: We posit that empowering citizens by providing them with a platform to safely store, manage and share their healthrelated data will be a necessary element in the transformation towards a more effective and efficient precision medicine. Such health data platforms should be organized as cooperatives that are solely owned and controlled by their members and not by shareholders. Members determine which data they want to share for example with doctors or to contribute to research for the benefit of their health and that of society. Members will also decide how the revenues generated by granting third parties access to the anonymized data that they agreed to share, should be invested in research, information or education. Results: Currently no functional Health Data Cooperatives exist yet. The relative success of health data repositories such as 23andme and PatientsLikeMe indicates that citizens are willing to participate in research even if - and in contrast to the cooperative model - the commercial value of these data does not go back to the collective of users. Conclusions: In the Health Data Cooperative model, the citizens with their data would take the center stage in the healthcare system and society would benefit from the health-related and financial benefits that aggregation of these data brings.

UR - http://www.scopus.com/inward/record.url?scp=84897951222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897951222&partnerID=8YFLogxK

U2 - 10.3414/ME13-02-0051

DO - 10.3414/ME13-02-0051

M3 - Article

C2 - 24514946

AN - SCOPUS:84897951222

VL - 53

SP - 82

EP - 86

JO - Methods of Information in Medicine

JF - Methods of Information in Medicine

SN - 0026-1270

IS - 2

ER -